BlackRock’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-206,681
Closed -$38.9K 5409
2024
Q1
$38.9K Hold
206,681
﹤0.01% 4925
2023
Q4
$41.7K Hold
206,681
﹤0.01% 4988
2023
Q3
$144K Sell
206,681
-19,618
-9% -$12.7K ﹤0.01% 4759
2023
Q2
$201K Buy
226,299
+88
+0% +$75 ﹤0.01% 4731
2023
Q1
$171K Sell
226,211
-290
-0.1% -$378 ﹤0.01% 4821
2022
Q4
$260K Sell
226,501
-370
-0.2% -$305 ﹤0.01% 4779
2022
Q3
$200K Sell
226,871
-574
-0.3% -$695 ﹤0.01% 4972
2022
Q2
$254K Sell
227,445
-1,016,229
-82% -$872K ﹤0.01% 4976
2022
Q1
$1.73M Sell
1,243,674
-43,501
-3% -$93K ﹤0.01% 4452
2021
Q4
$4.39M Buy
1,287,175
+15,574
+1% +$87.7K ﹤0.01% 4049
2021
Q3
$11.2M Buy
1,271,601
+200,749
+19% +$2.64M ﹤0.01% 3626
2021
Q2
$18.2M Buy
1,070,852
+150,351
+16% +$2.2M ﹤0.01% 3359
2021
Q1
$12.3M Buy
920,501
+265,946
+41% +$5.99M ﹤0.01% 3455
2020
Q4
$18.9M Sell
654,555
-25,431
-4% -$688K ﹤0.01% 3036
2020
Q3
$20.3M Buy
+679,986
New +$20.6M ﹤0.01% 2853

Other funds holding AFIB

BlackRock's AFIB Position: Q2 2024 in Review

BlackRock sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 206,681 shares — an estimated $38.9K sold.

BlackRock first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $20.3M in Q3 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • BlackRock reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 206,681 Acutus Medical Inc shares in Q2 2024, an estimated $38.9K.
  • BlackRock first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
  • BlackRock's Acutus Medical Inc position peaked at $20.3M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.